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INTRODUCTION
Asthma is a major health concern in all age groups, and the 
allergic form of asthma occurs due to a wide range of factors, 
including exposure to molds, pet dander, cockroaches, and 
ragweed.1,2 Early-life exposure to and sensitization with vari-
ous allergens, including cockroaches and Alternaria, have 
been noted in children with severe forms of asthma.3,4 Cock-
roaches produce several allergens, and exposure to increased 
levels of these allergens is a major risk factor in sensitized in-
dividuals.5,6 Previously, it was reported that cockroach aller-
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gens exhibit proteolytic activity, increasing inflammatory cy-
tokines in human airway epithelial cells, or a Toll-like receptor 
(TLR) 2 agonist that directly affects neutrophils, inducing an 
early innate immune response.7 Furthermore, it was shown 
that cockroach frass proteases can cleave pro-matrix metallo-
proteinase (MMP)9, which plays a role in airway remodeling.8
The MMP family includes zinc- and calcium-dependent en-
dopeptidases,9 which can degrade a variety of substrates, and 
they play crucial roles in the regulation of tissue remodeling 
and regeneration.10 The production and activity of MMPs are 
tightly controlled by transcriptional and post-translational 
mechanisms in combination with proenzyme activation and 
inhibition of active MMPs. However, when not tightly regulat-
ed, MMPs can become dangerous and have been shown to be 
involved in cancer metastasis and cardiovascular diseases. 
Recent studies revealed that MMP dysregulation occurs in 
chronic obstructive pulmonary disease, asthma, interstitial 
lung diseases, and lung cancer.11 MMP levels and/or activity 
in individuals with asthma were shown to be significantly 
higher than those in control subjects.12 Extensive studies have 
confirmed that MMP expression and activity of MMP1, 2, 3, 9, 
and 12 are associated with asthma pathogenesis and asthma-
associated airway remodeling.9 Using animal models, an in-
crease in MMP9 activity in airway mucosa was shown to be 
associated with epithelial damage, subepithelial basement 
membrane alterations, and subepithelial collagen deposition.13 
Additionally, epithelium-derived metalloproteinases were 
shown to be involved in the pathogenesis of asthma.14 
The airway epithelium is the first barrier to respond to envi-
ronmental triggers (e.g., pollution, viral infection, and aller-
gens) and is pivotal in asthma pathogenesis.15 Under physio-
logical conditions, the epithelium forms a highly regulated 
and impermeable tight junction-containing barrier. Tight junc-
tions comprise transmembrane proteins (e.g., occludin, clau-
dins, and junctional adhesion molecules) and peripheral mem-
brane proteins [e.g., zonula occludens (ZO), cingulin], which 
interact to form a complex protein network.16 Several reports 
demonstrated that the barrier function of the airway epitheli-
um is impaired in asthma, which enables allergen particles to 
penetrate the airway wall, inducing immune and inflammatory 
responses and causing tissue damage.17,18 Furthermore, MMP9 
has been shown to modulate tight junction integrity and cell 
viability directly in the human airway epithelium.19 
In this study, we demonstrated that German cockroach ex-
tract (GCE) induces MMP1 increase in NCI-H292 cells, which 
directly influences tight junction change. Furthermore, we dis-
covered that the MMP1-induced tight junction alteration is 
controlled by transcription factors (ETS1 and SP1) activation 
and extracellular signal-regulated kinase (ERK)/mitogen-acti-
vated protein kinase (MAPK) pathway. In addition, we noted 
that TLR2 might be involved in MMP1-induced tight junction 
disruption.
MATERIALs AND METHODs
Reagents
GCE was purchased from the Arthropods of Medical Impor-
tance Resource Bank, Yonsei University College of Medicine 
(Seoul, Korea). Small interfering RNAs (siRNAs) against AP1, 
NF-κB, SP1, ETS1, and MMP1 were purchased from Santa Cruz 
Biotechnology (Santa Cruz, CA, USA). Anti-TLR2 antibody 
and anti-phosphorylated and control p44/42 antibodies were 
purchased from R&D Systems (Minneapolis, MN, USA) and 
Cell Signaling Technology (Denvers, MA, USA), respectively. 
The broad-spectrum MMP inhibitor GM6001 and the MAPK/
ERK inhibitor PD98059 were purchased from Santa Cruz Bio-
technology and Cell Signaling Technology, respectively.
Cell culture
Human mucoepidermoid pulmonary carcinoma cells (NCI-
H292) (ATCC, Manassas, VA, USA) were plated into six- or 12-
well culture plates in RPMI 1640 supplemented with 10% fetal 
bovine serum and 100 U/mL penicillin and streptomycin (GE 
Healthcare Life Sciences, Logan, UT, USA). Their morphology 
is epithelial and culture properties are adherent (ATCC).
Real-time PCR
Total RNA was isolated from cells using TRIzol reagent, and 
cDNA was synthesized using random primers and SuperScript 
III reverse transcriptase (Invitrogen, Carlsbad, CA, USA). Real-
time PCR was performed with AccuPower GreenStar qPCR 
premix using ExicyclerTM 96 Real-Time Quantitative Thermal 
Block (Bioneer, Seoul, Korea), and mRNA expression levels 
were normalized to those of the housekeeping gene GAPDH. 
Primers are shown in Supplementary Table 1 (only online).
ELIsA
Human MMP1 and 9 protein levels in culture cell superna-
tants were determined using ELISA kits following the manu-
facturer’s instructions (R&D Systems). 
Western blotting
Following stimulation with GCE, cells were washed with cold 
phosphate-buffered saline (PBS) and lysed using M-PER sup-
plemented with proteases (Thermo Fisher Scientific, Waltham, 
MA, USA). Cell lysates were centrifuged at 12000 rpm for 5 min, 
and the total protein contents were analyzed using a Bradford 
assay (Bio-Rad, Hercules, CA, USA). Protein extracts were sub-
jected to 3.5–10% SDS-PAGE and Western blot analysis with 
anti-ZO-1 and anti-occludin antibodies (Invitrogen). Protein-
antibody complexes were observed using the X-ray films and 
the ECL detection kit (GE Healthcare, Amersham, UK).
Immunofluorescence
Following exposure to GCE, cells seeded onto the Nunclon 
Delta Surface (Thermo Fisher Scientific) were washed with 
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PBS, fixed in 4% paraformaldehyde for 20 min at room tem-
perature, incubated successively in 1 mM NH4Cl and 4% Tween, 
labeled with a primary antibody against ZO-1 and occludin 
for 1 h, and incubated with FITC-labeled goat-anti-mouse IgG 
conjugate (Invitrogen). Cell-antibody complexes were ana-
lyzed on an Olympus Fluo FV100 confocal microscope (Olym-
pus Corporation, Tokyo, Japan).
Electrical resistance
Transepithelial electrical conductance was monitored dose-
dependently using a volt-ohm meter and chopstick electrodes, 
according to manufacturer’s instructions (World Precision In-
struments, Sarasota, FL, USA). PBS was applied for each mea-
surement and then removed. 
siRNA transfection
Cells were transiently transfected with the siRNAs against NF-
κB, AP1, SP1, and ETS1 and siRNA against MMP1 using the 
TransIT-X2 Dynamic Delivery System (Mirus Bio, Madison, 
WI, USA) and were incubated in complete media overnight, 
following the manufacturer’s recommendations. After the GCE 
treatment, the supernatants were harvested for MMP1 ELISA, 
while the cells were prepared for MMP-1 qRT-PCR and West-
ern blot analysis of tight junction proteins.
Preparation of nuclear extracts and EMsA
Nuclear extracts from GCE-treated cells were prepared using 
NE-PER nuclear and cytoplasmic extraction reagents (Pierce, 
Rockford, IL, USA). Oligomers encoding the consensus se-
quences of NF-κB, AP1, SP1, and ETS1 were labeled with bio-
tin using a DNA 3' End Biotinylation kit. For the binding reac-
tions, 3 μg of nuclear protein extracts were incubated with 
binding buffer, poly (dI-dC), and biotin-labeled probe in a to-
tal volume of 20 μL for 20 min at 25°C, according to the manu-
facturer’s instructions (Pierce). The protein-DNA complexes 
were separated on a 6% polyacrylamide gel and transferred to 
a nylon membrane. The membrane was UV cross-linked, and 
the biotin-labeled DNA molecules were detected by chemilu-
minescence (Pierce).
statistical analysis
All data are presented as a mean±SEM, and differences be-
tween groups were analyzed using Student’s t-test. Data were 
analyzed using SPSS v.20 (IBM Corp., Armonk, NY, USA).
REsULTs
GCE induces MMP expression in airway epithelial cells
To investigate whether GCE can induce MMP expression, 
since some MMPs are found to be remarkably increased in 
asthmatic patients,12 we stimulated human airway epithelial 
cells (NCI-H292) with GCE (50 μg/mL) for 0–48 h. Afterwards, 
cells were harvested to determine MMP1, 2, 7, 9, 12, and TIMP1 
mRNA expression, while cell culture supernatants were uti-
lized to determine MMP protein levels using ELISA. As shown 
in Fig. 1A, GCE significantly induced only MMP1 (9.9-fold) 
and MMP9 (18.7-fold) mRNA expression at 6 h, compared 
with the GCE untreated cells as the control (n=3, p<0.05). Time-
course expression analyses showed that MMP1 significantly 
increased at 12 h after initial GCE treatment (23.2-fold, com-
pared to that at 0 h), while MMP9 expression peaked at 6 h and 
gradually decreased thereafter (Fig. 1B and C). Furthermore, 
as TIMP is known to be one of the important endogenous in-
hibitors of MMPs,12 we analyzed the expression of TIMP1 as 
well. However, no correlation among MMP1, 9, and TIMP1 ex-
pression following the GCE treatment was observed (Fig. 1D). 
Moreover, MMP1 and MMP9 protein levels in the supernatant 
(99.9±3.7 pg/mL to 1010.1±96.1 pg/mL and 10.3±0.7 pg/mL to 
58.0±1.8 pg/mL, respectively) at 6 h and 48 h after GCE treat-
ment were shown to be significantly higher than those the con-
trol (n=3, p<0.05) (Fig. 1E and F). However, as the MMP1 expres-
sion was shown to be much higher than MMP9, we continued 
our research focusing on MMP1. 
GCE leads to disruption of the cellular tight junction
We treated cells with GCE for 24 h and stained them with anti-
occludin or anti-ZO-1 antibody, since these proteins are impor-
tant indicators for the disruption of the cellular tight junction: 
Occludin plays a crucial role in the maintenance of tight junc-
tions and junction remodeling, while ZO-1 is involved in the 
establishment of the belt-like tight junctions. In addition, 
these proteins are known to closely interact, although the char-
acteristics and functional significance of the interaction are 
poorly understood.16 As shown in Fig. 2A, control cells (untreat-
ed) showed strong immunofluorescent staining, with clear in-
tercellular borders, while the GCE-stimulated cells displayed 
irregular and smeared staining patterns. Consistent with tight 
junction disruption, GCE treatment significantly and dose-
dependently decreased TEER (Fig. 2B). Meanwhile, occludin 
and ZO-1 mRNA expression did not significantly differ be-
tween controls and GCE-treated cells (Fig. 2C and D), where-
as occludin and ZO-1 protein expression decreased depend-
ing on the dose of GCE treatment (Fig. 2E and F). 
GCE-induced MMP1 expression leads to tight junction 
disruption
To determine the relationship between tight junction disrup-
tion and MMP1 release, cells were pretreated with an MMP 
inhibitor, GM6001, that can inactivate MMP1, 2, 3, 7, 8, 9, 12, 
14, and 26 for 1 h prior to the 24-h treatment with GCE. Con-
focal microscopy analysis showed that GCE-treated cells had 
discontinuous tight junctions, together with the altered local-
ization of occludin and ZO-1, whereas GM6001 prevented the 
cellular junctions from being disrupted (Fig. 3A). Further-
more, we determine that MMP1 siRNA transfected cells main-
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tained occludin and ZO-1 protein expression even after GCE 
treatment via immunoblotting analysis (Fig. 3B and C). The 
transfection efficiency of MMP-1 siRNA was confirmed by the 
measurement of MMP1 protein in the supernatant (Fig. 3D)
ETs1 and sP1 regulate GCE-induced MMP-1 expression 
that leads to tight junction disruption
Since it was reported that MMP1 expression and dysregula-
tion correlates with asthma severity relating to pulmonary ar-
chitecture remodeling and inflammation,20 we investigated 
the mechanisms by which GCE regulates MMP1 expression. 
First, we analyzed mRNA expressions of transcriptional fac-
tors, ETS1, SP1, AP1, and NF-κB, known to play important roles 
in MMP1 regulation.21,22 As shown in Fig. 4A and B, ETS1 and 
SP1 mRNA expression was highest at 6 h and 1 h, respectively, 
after GCE treatment (2.7-fold and 1.5-fold, respectively, p<0.01, 
compared with GCE untreated cells as the control; n=3). How-
ever, AP1 and NF-κB mRNA expression did not change (data 
not shown). Through EMSA analysis, we confirmed that ETS1 
abundantly translocated into the nucleus at 1 h after GCE treat-
ment, while SP1 did so at 2 h (Fig. 4C and D). Second, we evalu-
ated whether ETS1 and SP1 can regulate GCE-induced MMP1 
Fig. 1. Expression of matrix metalloproteinases (MMPs) and TIMP in human airway epithelial cells (NCI-H292) treated with German cockroach extract 
(GCE) for up to 48 h. (A) MMP1, 2, 7, 9, and 12 mRNA expressions at 6 h after GCE treatment. Time-dependent mRNA expression of (B) MMP1, (C) MMP9, 
and (D) TIMP1 was analyzed using real-time PCR. (E) MMP1 and (F) MMP9 protein expression were analyzed in the cell culture supernatants. Data are 
presented as the mean±SEM obtained in three independent experiments. *p<0.05, †p<0.01, ‡p<0.001, compared with control (ctrl, media only) or cells at 
0 h of media only. NS, not significant. 
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expression using siRNA transfection. The results indicated 
that ETS1, ETS2, and SP1 siRNA inhibit GCE-induced MMP1 
expression (74.4, 75.2, and 60.7% reduction, respectively, 
compared with the GCE-stimulated cells; n=3) (Fig. 4E and F). 
Furthermore, ETS1 and SP1 siRNA transfected cells were 
treated with GCE for 24 h and lysed for immunoblotting anal-
ysis to investigate tight junction protein expression. It was 
previously confirmed that cells transiently transfected with 
ETS1 and SP1 siRNA in media only show no difference in oc-
cludin and ZO-1 protein probed with anti-occludin and ZO-1 
(Supplementary Fig. 1, only online). In the result, the occludin 
protein expression did not significantly change against siRNA 
ETS1 and SP1 transfection after GCE treatment, while ZO-1 
protein expressions in ETS1 and SP1 siRNA transfected cells 
were not influenced by GCE (Fig. 4G and H).
ERK through TLR2 controls GCE-induced MMP-1 
expression, leading to tight junction protein decrease 
Furthermore, we investigated GCE-induced MAPK pathway 
activation using specific antibodies against phosphorylated 
ERK1/2, p38, and JNK (data not shown). While GCE activated 
the phosphorylation of ERK1/2 molecules (Fig. 5A), it did not 
activate p38 and JNK molecules (data not shown). Cell treat-
ment with PD98059, a potent inhibitor of MAPK/ERK, signifi-
Fig. 2. GCE induces tight junction and its proteins change. (A) Occludin and ZO-1 localization on GCE-stimulated cells was detected by immunofluores-
cence staining with anti-occludin or ZO-1 and observed under confocal microscopy. Scale bar represents 10 µm. (B) Transepithelial electrical resistance 
was measured after 24 hours of GCE treatment. (C) Occludin and (D) ZO-1 mRNA expression by time-dependent GCE treatment. *p<0.05 and †p<0.01, 
compared with control (ctrl, cells in media only). (E) Occludin and (F) ZO-1 protein expression by dose-dependent GCE treatment probed with anti-occlu-
din or ZO-1. Control (Ctrl) is protein from cells in media only probed with anti-occludin or ZO-1. Data are presented as the mean±SEM obtained in three in-
dependent experiments. Representative images are presented. GCE, German cockroach extract; ZO, zonula occludens; NS, not significant.
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cantly decreased GCE-induced MMP1 expression (n=3; 65.9% 
reduction, compared with that in the GCE only-treated cells; 
p<0.05) (Fig. 5B). Furthermore, this treatment prevented the 
GCE-induced translocation of ETS1 and SP1 (Fig. 5C and D). 
While PD98059 inhibitor did not affect GCE-induced occlu-
din decrease, it did prevent GCE-induced decreases in ZO-1 
levels (Fig. 5E and F). Additionally, we investigated whether 
TLRs, which play a key role in innate immune system re-
sponses, can affect GCE-induced MMP1 release, leading to 
tight junction alterations. A specific anti-TLR2 antibody pre-
vented GCE-mediated MMP1 expression (97% of reduction, 
compared with that in the GCE only-treated cells; n=3; p<0.01) 
(Fig. 6A) and GCE-induced decrease of occludin protein ex-
pression as well (Fig. 6B). However, ZO-1 protein expression 
was not affected by anti-TLR antibody pretreatment (Fig. 6C).
DIsCUssION
Cockroach allergen was shown to contain a protease that as-
sociates with PAR2 and TLR2 motifs, which can modulate in-
flammatory cytokine and chemokine activity, leading to direct 
activation of the innate immune system.5,7 Furthermore, cock-
roach extract increases bronchial airway epithelial permeabil-
ity, although the roles of different components have not been 
elucidated.23 Here, we demonstrated in vitro that GCE signifi-
cantly induces MMP1 expression. MMPs are key molecules in-
volved in cell proliferation and migration, tissue growth, re-
modeling, and regeneration and have high proteolytic activity 
and broad substrate specificity.10 Recently, MMPs were identi-
fied as likely to be involved in the pathogenesis of asthma, pri-
marily in the asthma-associated airway remodeling.24 Although 
the role of MMP9 in asthma pathogenesis has been extensive-
ly studied, the levels of other MMPs, including MMP-1, 2, 3, or 
12, in individuals with asthma were shown to be increased as 
well, indicating that their levels in sputum, BAL, and exhaled 
breath condensates correlate with disease exacerbation.25,26 
Additionally, it was reported that MMP1 is highly expressed in 
airway epithelial cells, inflammatory cells, and even airway 
smooth muscle cells in asthmatic patients.20,27,28 
Many studies have indicated that various aeroallergens, 
such as house dust mite and pollen, exhibit proteolytic activi-
ties, which may contribute to asthma pathogenesis by damag-
ing the barrier function of the airway epithelium.29,30 However, 
only a small number of studies have investigated the effects of 
cockroach allergen on the epithelial barrier.5 In this study, we 
selected occludin and ZO-1 as the indicators of tight junction 
disruption, because occludin is a key component of a tight 
seal formed between the cells and because ZO-1 directly in-
teracts with occludin to ensure proper localization of the tight 
junctions.16 We showed that GCE induces morphological 
changes and a GCE dose-dependent reduction of tight junc-
tion protein levels, in combination with an increase in the epi-
thelial permeability, suggesting that GCE may lead to the degra-
dation of epithelial tight junction proteins. Previously, cockroach 
antigen treatment was shown to induce VEGF expression and 
decrease electrical resistance in bronchial epithelial cells, al-
though the cockroach role was not investigated.23 To date, the 
activity of cockroach allergen has been explained by its effects 
on PAR2, which can lead to disease pathogenesis or exacerba-
tion.5 It was also suggested that these cockroach allergen ac-
tivities mediated by PAR2 may be further complicated by the 
involvement of TLRs, showing that cockroach allergen con-
tains both TLR4 and TLR2 motifs7 and that PAR2 and TLR4 
Occludin
ZO-1
Occludin
Actin
ZO-1
Actin
GCE + + -
Ctrl - - +
MMP1 siRNA - + +
GCE + + -
Ctrl - - +
MMP1 siRNA - + +
GCE + + -
Ctrl - - +
MMP1 siRNA - + +
Ctrl                                    GCE                     GCE+MMPs inhibitorA
B C
300
250
200
150
100
50
0
*
Hu
m
an
 M
M
P1
 p
ro
te
in
 (p
g/
m
L)
D
Fig. 3. GCE-induced MMP1 expression influences tight junction disrup-
tion. (A) Representative images show occludin and ZO-1 localization in 
cells pretreated with MMP inhibitor GM6001 and treated with GCE. Scale 
bar represents 10 µm. (B) Occludin and (C) ZO-1 protein was detected in 
cells transiently transfected with MMP1 siRNA and treated with GCE by 
anti-occludin or ZO-1. Representative images of three independent ex-
periments are presented. (D) MMP1 protein expression abundance was 
measured in the supernatant of cells transiently transfected with MMP1 
siRNA and treated with GCE by ELISA. *p<0.05, compared with the GCE 
only-treated cells. GCE, German cockroach extract; MMP, matrix metallo-
proteinase; ZO, zonula occludens; siRNA, small interfering RNA.
1228
Cockroach-Induced MMP1 Leads to Tight Junction Disruption
https://doi.org/10.3349/ymj.2018.59.10.1222
Ctrl + - - -
GCE - + + +
ETS1 siRNA - - + -
ETS2 siRNA - - - +
GCE + + + - - -
Ctrl - - - + + +
ETS1 siRNA - + - - + -
SP1 siRNA - - + - - +
GCE + + + - - -
Ctrl - - - + + +
ETS1 siRNA - + - - + -
SP1 siRNA - - + - - +
Ctrl + - -
GCE - + +
SP1 siRNA - - +
160
140
120
100
80
60
40
20
0
250
200
150
100
50
0
*
†*
Hu
m
an
 M
M
P1
 p
ro
te
in
 (p
g/
m
L)
Hu
m
an
 M
M
P1
 p
ro
te
in
 (p
g/
m
L)
E
G H
F
Fig. 4. GCE-induced MMP1 transcriptional regulation influences tight junction disruption. (A) ETS1 and (B) SP1 mRNA was expressed in GCE-treated 
cells. (C and D) Nuclear extracts were collected to assess the translocation of ETS1 and SP1. (E and F) MMP1 protein was measured in transiently trans-
fected cells with ETS1, ETS2, or SP1 siRNA and treated with GCE. (G and H) Cell lysates were collected to assess the expression of occludin and ZO-1 pro-
tein. Data are represented as the mean±SEM obtained in three independent experiments. *p<0.05, †p<0.01, compared with cells in media only or treated 
with GCE. Images are representative of three individual experiments. GCE, German cockroach extract; MMP, matrix metalloproteinase; ZO, zonula oc-
cludens; siRNA, small interfering RNA; NS, not significant.
2.0
1.5
1.0
0.5
0.0
6
5
4
3
2
1
0
0 h            1 h            2 h             6 h           12 h          24 h
1 h       2 h
GCE GCE
ETS1
1 h       2 h
SP1
0 h            1 h            2 h             6 h           12 h          24 h
NS
NS
*
*
Ctrl
GCE
Ctrl
GCE
NS
NS
NS
†
NS*
NS
NS
Hu
m
an
 S
P1
 m
RN
A 
(fo
ld
 in
cr
ea
se
)
Hu
m
an
 E
TS
1 
m
RN
A 
(fo
ld
 in
cr
ea
se
)
B
D
A
C
Occludin
Actin
ZO-1
Actin
1229
Kyung Eun Lee, et al.
https://doi.org/10.3349/ymj.2018.59.10.1222
signal cooperatively.31,32
Our data demonstrated that GCE induces MMP1 expression 
and tight junction disruption, which play important roles in 
disease-associated airway remodeling.19 Therefore, we inves-
tigated whether MMP1 cleaves occludin and ZO-1, the compo-
nents of tight junctions. In the result, GM6001, a potent MMP 
inhibitor, and MMP1 siRNA prevented the degradation of tight 
junction proteins, showing that tight junction disruption may 
be increased by GCE-induced MMP1 expression in airway epi-
thelial cells. MMP1 is a collagenase that can be detected in the 
small airways and lung parenchyma of asthmatic patients.33,34 
MMP1 expression was shown to directly correlate with the 
airway obstruction in BAL fluid and to be associated with the 
development of asthma symptoms, although the mechanisms 
thereof remain unclear.20,28,35 Inadequate tight junction forma-
tion has been confirmed in asthmatic samples, compared with 
normal cultures, using anti-ZO-1 and anti-occludin antibod-
ies, suggesting that respiratory viruses, air pollutants, and pro-
teolytically active allergens can cause epithelial desquamation 
through tight junction disruption and the disruption of epithe-
lial barrier function.18,20,29,30,36 
Although the role of MMPs in asthma pathogenesis has been 
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Fig. 5. ERK/MAPK pathway modulates MMP1 transcriptional regulation 
and tight junction disruption. (A) Phosphorylated and total ERK1/2 was 
detected in H292 cells pretreated with PD98059 for 1 h and treated with 
GCE for 24 h. (B) MMP1 protein was measured in the supernatant. Data 
are presented as the mean±SEM obtained in three independent experi-
ments. *p<0.05, compared with the GCE only-stimulated cells. (C) ETS1 
and (D) SP1 translocation were identified by the biotin-labeled probe of 
ETS1 or SP1. (E and F) Occludin and ZO-1 protein were immunoblotted 
with anti-occludin and ZO-1 in cells pretreated with PD98059 and treated 
with GCE. Images are representative of the results obtained in three inde-
pendent experiments. MMP, matrix metalloproteinase; GCE, German 
cockroach extract; ZO, zonula occludens; ERK, extracellular signal-regu-
lated kinase; MAPK, mitogen-activated protein kinase.
Fig. 6. TLR2 regulates MMP1 expression and might affect tight junction 
disruption. (A) MMP1 was measured in cells pretreated with anti-TLR2 
antibody and treated GCE. Data are presented as the mean±SEM ob-
tained in three independent experiments. †p<0.01, compared with the GCE 
only-treated cells. (B and C) Occludin and ZO-1 protein was detected in 
cells pretreated with anti-TLR2 and treated GCE by anti-occludin and 
ZO-1 antibody. Images are representative of the results obtained in three 
independent experiments. TLR2, Toll-like receptor 2; MMP, matrix metal-
loproteinase; GCE, German cockroach extract; ZO, zonula occludens.
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extensively researched, their inhibitors for potential therapeu-
tic purposes have rarely been developed. Therefore, under-
standing the molecular mechanisms underlying the regula-
tion of MMP1 expression may help identify potential targets 
for the prevention of disease development. MMP1 expression 
is tightly regulated at the levels of transcription, post-transcrip-
tion, and post-translation.37 At the transcriptional level, the 
promoter of MMP1, which contains adjacent binding sites for 
ETS1 and AP1 transcription factors, is known to be crucial for 
the regulation of MMP1 expression.21,38 The distal 1.5-kb seg-
ment of the MMP1 promoter was identified as necessary for 
the direct induction of MMP1 expression by cigarette smoke.39 
Moreover, NF-κB is a specific transcription factor that localizes 
to the promoter regions of MMPs in response to various stim-
uli.21,22 Here, we analyzed the involvement of these transcrip-
tion factors, ETS1, AP1, SP1, and NF-κB, in GCE-induced 
MMP1 expression, showing that both ETS1 and SP1 are sig-
nificantly activated and that their inhibition attenuates MMP1 
release and ZO-1 degradation. Furthermore, we investigated 
the signaling molecules mediating GCE-induced MMP1 re-
lease, and the TLR2 and ERK/MAPK pathway activation were 
shown to be required for the increase in MMP1 levels. Further, 
ERK/MAPK signaling molecules were shown to regulate ETS1 
and SP1 translocation induced by GCE, following TLR2 acti-
vation. MMP1 inhibition prevented tight junction degrada-
tion. Although TLRs are expressed on the majority of cells, 
they alone are not sufficient for the recognition of pathogens 
without coreceptors and adaptor molecules.7 The role of TLR2 
in asthma is controversial since different studies have shown 
that it can act as an enhancer or inhibitor of the allergy-related 
airway inflammation during sensitization.40 German cockroach 
frass was suggested to contain a TLR2 agonist that directly in-
duces neutrophils infiltration and further exacerbation of air-
way inflammation.7 Furthermore, it was reported that Staphy-
lococcus aureus induces MMP1 expression in human bronchial 
epithelial cells through the activation of TLR2/EGF receptor 
signaling axis.38 The AP1, NF-κB, SP1, and ETS transcription 
factors and MAPK family members were shown to play crucial 
roles in the MMP induction. MMP1 expression induced by one 
of the extracellular matrix proteins, tenascin-C, was shown to 
depend on ERK1/2, JNK, and p38 MAPK activation in airway 
smooth muscle cells.20 Cockroach frass-induced MMP9 ex-
pression can be upregulated by ERK activation and AP1 nu-
clear translocation.5
In conclusion, we demonstrated in this study that GCE in-
duces an increase in MMP1 release, known to be a pro-remod-
eling factor and to play a crucial role in tight junction disruption 
in airway epithelial cells. In order to assist the future develop-
ment of an MMP1 inhibitor, we identified transcription fac-
tors, such as ETS1 and SP1, and signaling molecules, such as 
TLR2 and ERK/MAPK, as regulating MMP1 expression. These 
molecules may represent potential targets for the develop-
ment of novel treatments for airway diseases such as asthma. 
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